Biopsy appears to be a safe and effective diagnostic strategy, although resection may be beneficial in selected unilateral thalamic tumours, although resection may be beneficial in selected unilateral thalamic tumours.
Surgical resection is the most reliable predictor of long-term tumor control, while proliferative markers appear to have limited prognostic value, and active surveillance is a safe approach for asymptomatic patients, while surgery remains the treatment of choice in symptomatic tumors or those showing growth.
Alessandro Bavaresco, F. Ceccato, P. Mazzeo et al.· European Journal of Endocrin...· 0 citations
Tumor–hypothalamus relationship emerged as the strongest determinant of surgical radicality, postoperative morbidity, and long-term survival, while EEA provided superior resection rates and lower complication rates.
S. de Sanctis, F. Valeri, G. Trevisi et al.· European Journal of Endocrin...· 0 citations
Background: Primary CNS lymphoma (PCNSL) is a rare form of extranodal lymphoma, representing 3 to 4% of brain tumors. We aim to report the clinicopathological features and predictors of survival in patients with PCNSL.
Materials and Methods: This retrospective study was conducted at Shifa International Hospital, Pakis...
Zujajah Hameed, Fatima Sharif, I. Ahmad et al.· International Journal of Hem...· 0 citations
Surgical resection significantly reduced tumor volume and relieved mass-effect symptoms, despite continued axis dysfunction, and postoperative metabolic changes included a significant increase in body mass index and lower LH levels were associated with a higher likelihood of hypopituitarism.
Aleksandra Derwich-Rudowicz, Abdulrahman Ammoun, Ikram Ghalmi et al.· European Journal of Endocrin...· 0 citations
In this contemporary multicenter cohort of 201 patients, surgical resection of cerebellar metastases achieved a median survival of about one year, and functional status and systemic disease burden remain the strongest predictors of outcome.
T. Araceli, Matthias Demetz, J. Rösler et al.· Neuro-Oncology Advances· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.